|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |review |
 |
Numerous
investigational approaches have been evaluated in the population of patients
with severe sepsis. They include bacterial modulators, anticytokines,
antiinflammatory agents, hemostatic agents, and other interventions.
Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;340:207-14.
|